- Lobbying
- Jason AND Van AND Pelt
Lobbying Arrangements Results for 'Jason Van Pelt'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to readiness and use of commercial software products. Issues related to funding of commercial software products. H.R.3219/Senate, Department of Defense Appropriations Act, 2018; H.R.... |
Paladin Data Systems
|
Crossroads Strategies, LLC | |||
Details Issues related to commercial airline competitiveness, efficiency, workforce development, infrastructure, and FAA Reauthorization; H.R.3684, Infrastructure Investment and Jobs Act (P.L.117-58) imple... |
Airlines for America
|
Crossroads Strategies, LLC | |||
Details Insurance regulation legislation including issues related to flood insurance, autonomous vehicles, risk and liability. Implementation of Tax Cuts and Jobs Act (P.L.115-97); H.R.5376, Inflation Redu... |
Marsh McLennan (formerly Marsh & McLennan Companies, Inc.)
|
Crossroads Strategies, LLC | |||
Details Legislative and regulatory issues affecting the railroad industry including rail antitrust, rail operations, rail safety, rail labor negotiations, and infrastructure; S.576/H.R.1674, Railway Safety... |
Norfolk Southern Corporation
|
Crossroads Strategies, LLC | |||
Details Advance the use of and access to FDA-approved medications to treat addiction and mental illness in criminal justice and public health settings; pharmaceutical supply chain issues; drug pricing. Imp... |
Alkermes, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), 340B Program, influenza, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, education... |
Genentech, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price c... |
Takeda Pharmaceuticals America, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, T... |
Merck & Co., Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price cap, and international pharmac... |
Bristol-Myers Squibb
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), Rx-to-OTC switch issues, influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutica... |
Sanofi US Services Inc.
|
Crossroads Strategies, LLC | |||
Details 340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; antimicrobial resistance ... |
Pharmaceutical Research and Manufacturers of America
|
Crossroads Strategies, LLC | |||
Details CBO modeling Drug Pricing Fiscal year 2024 Appropriations H.R. 5376, Inflation Reduction Act H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024 Importation Value of Med... |
NOVARTIS
|
in-house lobbying | |||
Details H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916,... |
Merck & Co, Inc.
|
in-house lobbying |